David D. Meek, Chief Executive Officer at Mirati Therapeutics, Inc. (MRTX), sold 9,232 shares at $40.41 ($373K) on 2022-12-21, disclosed to the SEC on 2022-12-21.
Open-market sale of $373k MRTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.41 | 4,616 | $187K | 50.0% |
| 2 | $40.41 | 4,616 | $187K | 50.0% |
| Total | $40.41 avg | 9,232 | $373K | 100% |
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |